![Can-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results - TheStreet Can-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results - TheStreet](https://www.thestreet.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cg_faces:center%2Cq_auto:good%2Cw_768/MTY4NjM0MjE3NjUyMTY4MzI3/dicks-sporting-goods-dks-stock-declines-pre-market-on-weak-first-quarter-sss.jpg)
Can-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results - TheStreet
![CANF - Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSEAM) CANF - Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSEAM)](https://images.fintel.io/us-canf-so.png)
CANF - Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSEAM)
![Can-Fite Biopharma Ltd - ADR Stock Forecast: up to 2.295 USD! - CANF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Can-Fite Biopharma Ltd - ADR Stock Forecast: up to 2.295 USD! - CANF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/69/stock-canf-stock-forecast.png?v=1713151933)
Can-Fite Biopharma Ltd - ADR Stock Forecast: up to 2.295 USD! - CANF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
![Can-Fite Biopharma Ltd ADR Stock News | CANF Company Stock News and Press Releases | User | theeveningleader.com Can-Fite Biopharma Ltd ADR Stock News | CANF Company Stock News and Press Releases | User | theeveningleader.com](https://investorplace.com/wp-content/uploads/2019/08/pills.jpg)
Can-Fite Biopharma Ltd ADR Stock News | CANF Company Stock News and Press Releases | User | theeveningleader.com
Can-Fite BioPharma Third Quarter 2023 Earnings: US$0.001 loss per share (vs US$0.003 loss in 3Q 2022) - Simply Wall St News
![Can-Fite Biopharma Ltd - ADR Stock Forecast: up to 2.295 USD! - CANF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Can-Fite Biopharma Ltd - ADR Stock Forecast: up to 2.295 USD! - CANF Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/69/stock-canf-stock-forecast-components.png?v=1713151933)